M
Martine Extermann
Researcher at University of South Florida
Publications - 188
Citations - 14482
Martine Extermann is an academic researcher from University of South Florida. The author has contributed to research in topics: Cancer & Geriatric oncology. The author has an hindex of 52, co-authored 162 publications receiving 12660 citations. Previous affiliations of Martine Extermann include Moffitt Cancer Center.
Papers
More filters
BookDOI
Biological Basis of Geriatric Oncology
TL;DR: The influence of Advanced Age on Cancer Occurrence and Growth and the management of the Older Cancer Patient are studied.
Journal ArticleDOI
The impact of polypharmacy on toxicity from chemotherapy in elderly patients: Focus on cytochrome P-450 inhibition and protein binding effects
TL;DR: The impact of polymedication on toxicity from chemotherapy is analyzed in a cohort of 290 patients 70+ receiving chemotherapy at Moffitt Cancer Center, using weighted effects according to the strength of p450 inhibition/induction.
Journal ArticleDOI
Impact of age, comorbidity, and treatment characteristics on survival in older women with advanced high grade epithelial ovarian cancer.
Adrianne Mallen,Sarah L. Todd,Sharon E. Robertson,Jongphil Kim,Marina Sehovic,Robert M. Wenham,Martine Extermann,Hye Sook Chon +7 more
TL;DR: In this paper, a retrospective chart review identified 351 patients who underwent cytoreductive surgery (CRS) and 100/351 (28.5%) were ≥ 70 years old.
Journal ArticleDOI
Phase 2 study of concurrent cetuximab plus definitive thoracic radiation therapy followed by consolidation docetaxel plus cetuximab in poor prognosis or elderly patients with locally advanced non-small cell lung cancer.
Thomas J. Dilling,Martine Extermann,Jongphil Kim,Lora M. A. Thompson,Binglin Yue,Craig Stevens,Scott J. Antonia,Jhanelle E. Gray,Charles Williams,Eric B. Haura,Mary Pinder-Schenck,Tawee Tanvetyanon,Sungjune Kim,Alberto Chiappori +13 more
TL;DR: Patients enrolled in this trial had improved OS compared with poor- PS historical controls and comparable OS to good-PS historical controls treated with XRT alone, however, pulmonary toxicity is a concern.
Journal ArticleDOI
The impact of fatigue and anemia on functional status in older cancer patients treated with chemotherapy
A. Luciani,A. Luciani,Paul B. Jacobsen,Martine Extermann,Paolo Foa,D. Marussi,Daris Ferrari,Alberto Morabito,Janine Overcash,Lodovico Balducci +9 more
TL;DR: Fatigue is almost universal in older cancer patients at the end of chemotherapy treatment and is associated with functional dependence, especially IADLs, especially PS.